← Back to the Research Desk · Published May 3, 2026 · 14 min read · Greg Taylor, CFA

Rocket Lab Into Q1 Earnings: The $45 Billion Question Behind the $600 Million Business

Rocket Lab reports Q1 2026 after close on Thursday, May 7. The consensus expects revenue between $185–200 million (per company guidance), EPS of roughly −$0.07, and an Adjusted EBITDA loss in the $21–27 million range. None of those numbers are what matters.

What matters is whether the narrative that has propelled a $600 million annual revenue company to a $45 billion market capitalization can survive the next 12 months of execution.

Where the Business Actually Stands

Rocket Lab closed 2025 with record annual revenue of $602 million, up 38% year-over-year. Q4 alone contributed $180 million, up 36% year-over-year and 16% sequentially. The backlog exited the year at $1.85 billion, up 73% from the prior year, representing roughly three years of revenue coverage at the current run rate.

The business operates in two segments that have quietly shifted in importance. Space Systems— the satellite design, manufacturing, and components business — now accounts for 74% of revenue at $403 million in 2025, up from $311 million in 2024. Launch Services contributed $199 million. This ratio matters: the market talks about Rocket Lab as a launch company, but three-quarters of its revenue comes from building satellites and selling components.

Gross margins have been improving. The Q1 2026 guide calls for 34–36% GAAP and 39–41% non-GAAP. For context, Q3 2025 posted record non-GAAP gross margins. The margin expansion story is real, but it’s being consumed by R&D, which jumped 55% to $271 million in 2025. Nearly all of that increase is Neutron development costs — the tank investigation, redesign, expanded test campaign, and Archimedes engine testing. Until Neutron enters production and R&D normalizes, operating profitability remains a 2027-and-beyond conversation.

Liquidity is not a concern. Rocket Lab ended Q4 with $977 million in cash and marketable securities against $265 million in debt, yielding a net cash position of roughly $834 million ($1.44/share). They also have a $1 billion ATM equity facility in place. At current burn rates, they have ample runway through Neutron’s debut and into 2027 without needing to tap the ATM aggressively.

The Contract Stack

Three contracts define the near-term trajectory.

The SDA Tracking Layer Tranche 3 award— $816 million for 18 advanced missile warning and tracking satellites — was the company’s single largest contract ever. This is prime contractor work, not subcomponent supply. It positions Rocket Lab as a defense satellite prime alongside Northrop Grumman and Lockheed Martin, but at a fraction of the overhead structure. Combined with earlier SDA Tranche 2 work, Rocket Lab now holds roughly $1.3 billion in SDA prime contracts involving 36 satellites.

The HASTE block buy— $190 million for 20 hypersonic test launches over four years under the MACH-TB 2.0 program — pushes total backlog above the $2 billion mark when combined with new Electron contracts signed in Q1. This contract validates the HASTE suborbital variant as a recurring defense revenue stream independent of Neutron’s development timeline.

The Mynaric acquisition, which closed April 14 for $155.3 million, adds laser optical communications terminals to Rocket Lab’s vertically integrated stack. Mynaric’s CONDOR Mk3 terminals are already subcontracted into the SDA satellite programs. Bringing this in-house eliminates a supply chain bottleneck that has plagued constellation operators across the industry. It also establishes Rocket Lab’s first European footprint through Mynaric’s Munich headquarters, opening the door to German and broader European defense space programs.

The Neutron Question

Every earnings call for the next two quarters will begin and end with Neutron. Here is where it stands.

On January 21, a Stage 1 propellant tank ruptured during hydrostatic pressure testing at Rocket Lab’s Maryland facility. The root cause was a manufacturing defect at a joint that was hand-laid by a third-party contractor. The tank was a test article, never intended to fly. The defect was introduced because Rocket Lab used a contractor to build the first test tank while its own Automated Fiber Placement (AFP) machine was still being commissioned.

The AFP machine is now operational. It is a 90-tonne autonomous system — the largest carbon composite AFP machine of its kind — that builds tanks precisely and consistently, eliminating the hand-laid defect entirely. The next tank is being built on this machine. CEO Peter Beck stated on April 16 that Neutron remains on track for a Q4 2026 first launch.

More important than the tank timeline is the Archimedes engine program. Beck told Stocktwits in April that the engine is undergoing what he called “nasty” tests — deliberately reducing propellant pressures to simulate re-entry conditions, testing what happens when ullage gases mix with remaining propellant. These tests are designed to validate reusability, which is Neutron’s core differentiator. Beck’s framing was telling: getting the rocket to orbit is straightforward, but making it reliably reusable is where the real engineering risk lives.

The other major Neutron subsystems — the Hungry Hippo captive fairing, the Stage 2 structure and systems, the launch complex at Wallops Island, the avionics and GNC stack — have all completed qualification. The tank and engine are the remaining critical-path items.

Valuation: The Tension

This is where the CFA in you should get uncomfortable.

At roughly $45 billion market cap on $602 million in trailing revenue, Rocket Lab trades at approximately 75x trailing price-to-sales. Even on the consensus FY2026 estimate of ~$894 million (49% growth), the forward P/S is roughly 50x. The company is not profitable. Operating margin was −38% in FY2025. Morningstar’s quantitative fair value sits at $15.67 — implying the stock is trading at an 819% premium.

The bull case doesn’t run through a DCF model. It runs through comparable positioning. SpaceX, reportedly targeting an IPO at a valuation above $2 trillion, has reset what the market is willing to pay for integrated space infrastructure. If SpaceX IPOs at 30–40x forward revenue, the valuation umbrella for the rest of the sector lifts accordingly. Rocket Lab is the most credible “SpaceX alternative” story in public markets — the only company with a proven small launch vehicle (85+ successful Electron flights, 100% success rate in 2025), a medium-lift vehicle in advanced development, a growing space systems business with $1.3 billion in defense prime contracts, and a demonstrated ability to vertically integrate through acquisition.

The bear case is more traditional. The company generated −$198 million in net losses in 2025. Shares outstanding have grown 7% year-over-year through equity issuance. Insider selling has been notable — roughly $16.5 million sold in the most recent quarter. Cathie Wood’s ARK has been trimming its RKLB position. Short interest has risen 26.6% to 31.5 million shares (5.5% of float). The stock’s beta is 2.21, meaning it amplifies both market rallies and selloffs.

The honest middle ground: Rocket Lab’s valuation is defensible only if you believe three things simultaneously. First, that Neutron will fly successfully in 2026–2027 and achieve reusability, opening the medium-lift market (an estimated $10 billion addressable market). Second, that Space Systems will continue scaling at 30%+ growth rates as SDA deliveries ramp and the Mynaric acquisition contributes. Third, that the space economy writ large is entering a sustained multi-year expansion driven by defense proliferation, commercial constellation buildout, and national security space spending.

If all three hold, the current valuation is reasonable in the context of a company transitioning from a $600 million business to a multi-billion-dollar integrated space platform. If any one of them breaks — if Neutron fails on first flight, if SDA program margins compress, if the space spending cycle turns — the 75x trailing P/S provides no margin of safety.

What to Watch on May 7

Revenue and guidance.Did Q1 come in at or above the $185–200 million guide? More importantly, does Q2 guidance show sequential acceleration? Consensus for FY2026 is ~$894 million, implying roughly $220–240 million per quarter in the back half. The ramp rate from Mynaric consolidation and SDA deliveries will be the driver.

Backlog update.The $1.85 billion figure will be stale. With HASTE block-buy, new Electron contracts, and potential new SDA or commercial awards, backlog could approach or exceed $2.2 billion. Watch for the composition — how much is launch vs. space systems, and how much is new vs. recognized.

Neutron specifics.Any movement on AFP tank testing, Archimedes engine test campaign milestones, or the first customer manifest slot. A reaffirmation of “Q4 2026” is the minimum expectation. Anything more specific (month, customer) would be positive. Anything vaguer would be a red flag.

Margin trajectory.GAAP gross margins in the 34–36% guide range would be slightly below Q3 2025’s record. If Mynaric integration costs compress margins temporarily, management needs to frame the near-term drag against the long-term vertical integration thesis.

Cash burn and ATM usage. How much of the $1 billion ATM has been tapped in Q1? The 7% year-over-year increase in shares outstanding is dilutive but manageable if revenue growth outpaces it. Watch the ratio.

NSSL Lane 1.Rocket Lab has been pursuing the National Security Space Launch Lane 1 program, an IDIQ contract valued at $5.6 billion over five years. Any update on Neutron’s certification path for NSSL onboarding would be a significant catalyst.

The Bottom Line

Rocket Lab is executing a playbook that looks nothing like a traditional launch company. It’s building a vertically integrated space systems conglomerate — satellites, components, laser comms, propulsion, launch vehicles — at a pace that has no historical analog outside of SpaceX. The FY2025 numbers demonstrate that the core business is real and growing. The backlog provides multi-year visibility. The balance sheet is strong enough to fund operations through Neutron’s debut.

The risk is binary and concentrated: Neutron. If the rocket flies successfully and demonstrates reusability, the TAM expansion justifies a valuation that traditional metrics can’t. If it doesn’t, or if it slips into 2027, the stock is priced for a future that keeps receding.

For investors going into May 7: the Q1 numbers themselves are unlikely to surprise in either direction, given the tight guidance range. This call is about Neutron milestones, backlog composition, and forward guidance trajectory. That’s where the stock moves.